您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。[港股财报]:艾美疫苗2024年度报告 - 发现报告

艾美疫苗2024年度报告

2025-04-25港股财报H***
AI智能总结
查看更多
艾美疫苗2024年度报告

(於中華人民共和國註冊成立的股份有限公司)股份代號:06660 年 度 報 告2024 目 錄 25732405859859091939496191192 202541720254132025417 2025417Ker Wei PEI20254 17 2025413 Ker Wei PEI2025413 2025417202541720254172025413Ker Wei PEI20254 1720254172025417 Ker Wei PEI20254132025417 10564412 2025417202541720254132025417 2T626 ACGHKACG 331919182025110 97927 H 1617 153232033207 25 399 06660 www.aimbio.com 2024 mRNA VeromRNA 2313202423III13 mRNAmRNAmRNA RSVmRNAmRNAmRNA RSVmRNA mRNA21TOP10 2025 CEO2025328 mRNA312,0008VeroACY W135(MPSV4)2113IIImRNAmRNAmRNAmRNA 20211323 202413(PCV13) III 23(PPSV23)III 4(CDE)mRNA RSVMDCK2(CDE)mRNA(FDA)mRNA RSVmRNA(FDA)220(PCV20)b(Hib) 2024Vero VeroACYW135(MPSV4) +202412311,285.020238.2% 1121132013(PCV13)III23(PPSV23)IIIIIIACY W135(MCV4)IIEV71-CA16MDCK(CDE)mRNA RSVCDEFDAmRNA(FDA)(CDE)20(PCV20)b(Hib) (CHO)20325 203090%65%202220224(ACIP)1959 10μg/0.5ml20μg/0.5ml10μg20μg16160.5ml20μg0.5ml100% Vero Vero2007920086GMP 2007Vero17100%mRNA (HAV)HAV115320Eu/0.5ml15640Eu/1.0ml20215920219202262022GMP ACYW135(MPSV4) 20203MPSV4MPSV4ACY W135201810MPSV4201812GMPMPSV4MPSV4MPSV4(MCV4)II (1)13(PCV13)(2)23IIIIII(3)20(4)24 PCV136712024PCV13 PCV132024PCV13III71IIIPCV13 136620302001325.9%80% 131.813 GMP1323III (1)(2) Vero mRNAmRNAmRNA mRNA mRNAmRNA mRNA RSVmRNAmRNAGSKRSV20235202324.6GSK202343.7mRNAmRNA RSV(CDE)(FDA)mRNA(FDA)(CDE)mRNA mRNA ACYW135(MCV4) (MPSV)122MCV4MCV4MCV2MCV4MCV4ACYW1353II EV71-CA16 71(EV71)A16(CA16)CA16CA16EV71-CA16EV71-CA16EV71CA16 mRNAAImRNAAI (i)(ii)mRNAmRNAmRNAmRNA 20241231GMP20241231 201912 1 2022–2023850.71,017.719.6%2024 20242.546,00020247 281420242020202410HBsAg5.86%HBV7,500272024 2002HBV12024–20302025–2030 mRNAmRNAmRNAmRNAmRNAmRNADNAmRNAFDA2018FDAmRNA252023mRNAFDA982022mRNA2FDAFDAmRNAmRNA PCV13PPSV232018PCV1334.6%65.6%2022PCV1372.6%88.3%PPSV23PCV132022107.522.7%2025240PCV13PCV20 PCV24PCV 20195,88020217,85033.6%2030220203035.0%mRNA2030mRNA21.2% 2024RSVRSVRSV20245 31mRNA RSVmRNAmRNA2030RSV154 mRNA20302390.1%2030200 2015202261719.4%203012.3%2,203mRNA 2024MPSV4 2024–202613 VeroACYW135(MPSV4) GMP1323III 20251323mRNA 20241,285.020231,187.597.58.2% 2024331.52023286.545.015.7% 2024953.52023901.052.55.8% 202474.2%202375.9%1.7% 202432.8202351.618.836.4%6.9 2024363.12023636.4273.342.9%202423III23 2024542.72023494.048.79.9% 2024282.72023254.328.411.2% 20246.220234.210.4249.7% 2024123132.7 202460.8202343.817.038.7% 202412.22023320.4308.296.2%20241231 2024278.420231,950.21,671.885.7% 202412 31594.9202312 31736.4141.519.2% 202412 312,387.43,090.3702.9202312 31119.0583.91323 20241231462.6202312 31509.947.39.3% 202412311,123.8202312311,005.1118.711.8% 2024238.320242023301.663.321.0%48 202412311,841.3202312 311,795.645.72.5% 2024123151.0%2023123146.2%4.8% 20241231(1)20241231249.7202312 31259.4(2)2024123171.1202312 3159.0(3) 20241231 20241231 2024123120241231 202412311,535202312311,6242024356.92023362.4 , 91.61202310 2320241231 (1)202312mRNA(2)20236PCV13PCV20PPSV23(3)202412mRNA(4)20231 2024202412 31 59201552021692020122021520215 102012520122021630201352018811520111020135 20141220155W.P.W.P.20221 562013520216 920242 292024829 20106202012 201220226 622017820216 920254 17202121820254 17202332920254172020122021320216 20174202122007120173199882007960121126111992919998 1986720065W.P. 582021220216 920242292025417201612202062021220213 20151120168201410201511 2014320089 612015520216 920248 292024820151220161220161220209 201252013520175 20139 6120206202169 20232201722013120171200232013119842200211982919841 200672015W.P.19978 Ker Wei PEI682020919 Pei1998720225W.P.1986119926W.P.1992719987199872003620037201362013720176Pei199719931994 Pei201260576200760151200860672Pei2015720191212082006520125600019201562022122012220199Pei20184 Pei197961981519865 532021218 2017920212201132017101998220112 1993620091020214 612021528 201432011320143200182011230067619853200172004 1981202112 311997 201511SARS 5620212 2012520191220106201112200612201062003720061260051120106201112300290201453000242022520000989 1999620026200272005 63201512 25200891992820088 1986719926 292013620206 2018919 CEO 52201510 200612201112 1993620205W.P.20061220096 422011112015112022320215 2019122021620142201912007820115 20185W.P. 3920213 20195202132019820213201952019820139201842010520132 201712 4720181020223 2011220181020081220112 20215SPACE 6120224 2020420138202041985720138 1985719921994199412 2024 H20221062022923(www.hkexnews.hk)(www.aimbio.com) 1 5673139 392328 C2 20241231 191 13 2024123130% 2024123130% 202210 6H16.169,714,000H20221028H16.161,348,600H91.61 2024123129 31 2024123120231231 20242 2920248 2920254172024829 202482920248292025413 Ker Wei PEI2025413 3239 13.51(2)13.51B(1) 13.51(2)13.51B 20201 11,979202011202412319,540,0000.5 202412318.10 20241231 89 2.4 20241231XVXV78352 (1) (2)202412311,211,062,599718,888,888492,173,711H (3)20241231200,000,0001,326,800H99.99%200,000,00010,135,23523,254,765H (4)5